High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability
- PMID: 22509352
- PMCID: PMC3324537
- DOI: 10.1371/journal.pone.0034739
High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability
Abstract
Intellectual disability (ID) is a heterogeneous disorder caused by chromosomal abnormalities, monogenic factors and environmental factors. 22q13 deletion syndrome is a genetic disorder characterized by severe ID. Although the frequency of 22q13 deletions in ID is unclear, it is believed to be largely underestimated. To address this issue, we used Affymetrix Human SNP 6.0 array to detect the 22q13 deletions in 234 Chinese unexplained ID patients and 103 controls. After the Quality Control (QC) test of raw data, 22q13 deletions were found in four out of 230 cases (1.7%), while absent in parents of the cases and 101 controls. A review of genome-wide microarray studies in ID was performed and the frequency of 22q13 deletions from the literatures was 0.24%, much lower than our report. The overlapping region shared by all 4 cases encompasses the gene SHANK3. A heterozygous de novo nonsense mutation Y1015X of SHANK3 was identified in one ID patient. Cortical neurons were prepared from embryonic mice and were transfected with a control plasmid, shank3 wild-type (WT) or mutant plasmids. Overexpression of the Y1015 mutant in neurons significantly affected neurite outgrowth compared with shank3 WT. These findings suggest that 22q13 deletions may be a more frequent cause for Chinese ID patients than previously thought, and the SHANK3 gene is involved in the neurite development.
Conflict of interest statement
Figures
Similar articles
-
Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations.Mol Autism. 2018 Apr 27;9:31. doi: 10.1186/s13229-018-0205-9. eCollection 2018. Mol Autism. 2018. PMID: 29719671 Free PMC article.
-
A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.Orphanet J Rare Dis. 2020 Nov 30;15(1):335. doi: 10.1186/s13023-020-01592-5. Orphanet J Rare Dis. 2020. PMID: 33256793 Free PMC article.
-
Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.Am J Med Genet A. 2014 Jul;164A(7):1666-76. doi: 10.1002/ajmg.a.36513. Epub 2014 Apr 3. Am J Med Genet A. 2014. PMID: 24700646
-
Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review.BMC Med Genomics. 2020 Oct 6;13(1):146. doi: 10.1186/s12920-020-00802-0. BMC Med Genomics. 2020. PMID: 33023580 Free PMC article. Review.
-
A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C.Am J Med Genet A. 2018 Dec;176(12):2791-2797. doi: 10.1002/ajmg.a.40492. Epub 2018 Sep 14. Am J Med Genet A. 2018. PMID: 30216695 Review.
Cited by
-
Modeling autism by SHANK gene mutations in mice.Neuron. 2013 Apr 10;78(1):8-27. doi: 10.1016/j.neuron.2013.03.016. Neuron. 2013. PMID: 23583105 Free PMC article. Review.
-
Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.J Child Neurol. 2015 Dec;30(14):1861-70. doi: 10.1177/0883073815600872. Epub 2015 Sep 8. J Child Neurol. 2015. PMID: 26350728 Free PMC article. Review.
-
Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations.Mol Autism. 2018 Apr 27;9:31. doi: 10.1186/s13229-018-0205-9. eCollection 2018. Mol Autism. 2018. PMID: 29719671 Free PMC article.
-
Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat.Elife. 2017 Jan 31;6:e18904. doi: 10.7554/eLife.18904. Elife. 2017. PMID: 28139198 Free PMC article.
-
A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.Orphanet J Rare Dis. 2020 Nov 30;15(1):335. doi: 10.1186/s13023-020-01592-5. Orphanet J Rare Dis. 2020. PMID: 33256793 Free PMC article.
References
-
- Daily DK, Ardinger HH, Holmes GE. Identification and evaluation of mental retardation. Am Fam Physician. 2000;61:1059–1067, 1070. - PubMed
-
- Chelly J, Khelfaoui M, Francis F, Chérif B, Bienvenu T. Genetics and pathophysiology of mental retardation. Eur J Hum Genet. 2006;14:701–713. - PubMed
-
- Knight SJL, Regan R. Idiopathic learning disability and genome imbalance. Cytogenet Genome Res. 2006;115:215–224. - PubMed
-
- Koolen DA. Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Hum Mutat. 2009;30:283–292. - PubMed
-
- Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JPT, et al. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med. 2009;11:139–146. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
